Kindred Healthcare
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kindred Healthcare generated cash of $75,695,000, which is less than the previous year. Cash used in financing activities reached the amount of -$163,813,000 last year. Net change in cash is therefore $23,193,000.
Cash Flow
| 2013 | 199.41M | -126.19M | -87.25M |
|---|---|---|---|
| 2014 | 105.47M | -1.68B | 1.70B |
| 2015 | 163.26M | 752.20M | -980.90M |
| 2016 | 184.96M | -199.64M | 52.98M |
| 2017 | 75.69M | 111.31M | -163.81M |
KND Cash Flow Statement (2013 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|
Cash at beginning of period | 137.06M | 98.75M | 164.18M | 35.97M | 50.00M |
Operating activities | |||||
Net income | -643.31M | -610.62M | -52.09M | -61.43M | -164.83M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 117.11M | 159.63M | 158.37M | 160.95M | 182.38M |
Stock-based compensation expense | 864.42M | 414.76M | 111.57M | 95.10M | 239.44M |
| Deferred income tax benefit | 864.42M | 414.76M | 111.57M | 95.10M | 239.44M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -20.89M | -59.03M | -8.57M | -74.37M | 52.27M |
Inventories | 22.85M | -24.22M | 54.49M | -25.96M | 4.26M |
Accounts payable | -12.26M | 26.21M | -10.38M | -9.39M | -22.09M |
Cash generated by operating activities | 75.69M | 184.96M | 163.26M | 105.47M | 199.41M |
Investing activities | |||||
Purchases Of Investments | -113.66M | -129.63M | -89.84M | -105.32M | -46.12M |
Investments In Property Plant And Equipment | -95.70M | -130.87M | -141.86M | -96.33M | -112.73M |
Acquisitions Net | -9.65M | -78.84M | -673.54M | -24.13M | -224.31M |
Cash generated by investing activities | 111.31M | -199.64M | 752.20M | -1.68B | -126.19M |
Financing activities | |||||
Common Stock Issued | 32K | 0 | 534K | 328.21M | 461K |
Payments for dividends | -22.6M | -52.25M | -51.00M | -28.59M | -13.00M |
Repurchases of common stock | 0 | 0 | -915K | 4.43B | 1.67B |
Repayments of term debt | -77.57M | -1.70B | -888.52M | -3.14B | -1.74B |
Cash used in financing activities | -163.81M | 52.98M | -980.90M | 1.70B | -87.25M |
Net Change In Cash | 23.19M | 38.30M | -65.43M | 128.21M | -14.03M |
Cash at end of period | 160.25M | 137.06M | 98.75M | 164.18M | 35.97M |